Almay Clear Complexion Concealer

Description

ALM CC CONCEALER ART is presented in a media type of image/jpeg, with a reference image labeled as ALMAY CC CONCEALER CARD.jpg. The product is designed for professional use, providing a visual representation of its formulation and application.

Uses and Indications

This drug is indicated for the treatment of acne. It helps to clear existing acne blemishes and prevent the formation of new acne lesions.

Dosage and Administration

Healthcare professionals should ensure that the skin is thoroughly cleaned prior to the application of this product. The product should be applied as a thin layer to the entire affected area one to three times daily, depending on the patient's needs and the physician's recommendations.

To minimize the risk of excessive skin drying, it is advisable to initiate treatment with one application per day. The frequency may be gradually increased to two or three times daily as tolerated. In cases where bothersome dryness or peeling occurs, the application frequency should be reduced to once daily or every other day.

For new users, a sensitivity test is recommended. This involves applying the product sparingly to one or two small affected areas during the first three days of use. If no discomfort is experienced, the user may then proceed to follow the standard application instructions.

Contraindications

Use of this product is contraindicated in the following situations:

• The product should be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a poison control center is required.

Warnings and Precautions

When using this product, it is important to be aware of the potential for skin irritation and dryness, particularly if another topical acne medication is being used concurrently. To minimize the risk of irritation, it is recommended that only one topical acne medication be applied at a time.

Care should be taken to avoid contact with the eyes. In the event of accidental contact, it is essential to flush the eyes thoroughly with water to mitigate any potential adverse effects.

This product should be kept out of reach of children. In the case of accidental ingestion, immediate medical assistance should be sought, or a poison control center should be contacted without delay.

Side Effects

Patients using this medication may experience skin irritation and dryness, particularly if they concurrently use another topical acne medication. It is advised that only one topical acne medication be used at a time to minimize the risk of irritation.

Additionally, patients should avoid contact with the eyes. In the event of contact, it is recommended to flush the eyes thoroughly with water to alleviate any potential discomfort.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate this risk, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of one of the medications should be considered to alleviate symptoms. Monitoring for signs of skin irritation is recommended when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Almay Clear Complexion Concealer (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this product out of reach of children. In the event that the product is swallowed, it is crucial to seek medical assistance or contact a poison control center immediately.

Geriatric Use

There is no specific information regarding the use of ALMAY CLEAR COMPLEXION CONCEALER in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when considering the use of this product in elderly patients, as the absence of data does not preclude the potential for age-related differences in pharmacokinetics or safety profiles. Monitoring for any adverse effects is advisable when this product is used in the geriatric population.

Pregnancy

The safety of salicylic acid during pregnancy has not been established, and its use is contraindicated due to potential risks to the fetus. There is a recognized risk of teratogenic effects associated with the use of salicylic acid during pregnancy. Therefore, the use of salicylic acid should be avoided or limited in pregnant patients. Healthcare providers should be consulted for alternative treatment options. Pregnant women are advised to discuss the use of this product with their healthcare provider prior to use to ensure the safety of both the mother and the developing fetus.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution when administering the medication. It is essential to monitor patients closely for any signs of adverse effects or symptoms that may arise from excessive dosing.

In the event of suspected overdosage, immediate medical attention should be sought. Healthcare providers should implement supportive measures as necessary, which may include symptomatic treatment and monitoring of vital signs.

Due to the lack of detailed overdosage information, it is recommended that healthcare professionals refer to established clinical guidelines and protocols for managing overdose situations relevant to the specific medication in question. Additionally, contacting a poison control center may provide further guidance on appropriate management strategies.

Continued vigilance and patient assessment are crucial in mitigating potential risks associated with overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children to prevent accidental ingestion. In the event that the product is swallowed, patients should be instructed to seek medical help or contact a poison control center immediately. It is essential for patients to understand the importance of these precautions to ensure their safety and the safety of others.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers, which should be referenced for accurate identification. It is essential to store the product at room temperature to maintain its integrity. Additionally, the product must be protected from light exposure to prevent degradation.

To ensure optimal preservation, the container should be kept tightly closed when not in use. It is important to note that the product should be discarded after opening to ensure safety and efficacy.

Additional Clinical Information

The product is administered topically, with a recommended application of a thin layer to the entire affected area one to three times daily. Patients should begin with one application daily to minimize the risk of excessive skin drying, gradually increasing to two or three times daily as needed or directed by a clinician. If dryness or peeling becomes bothersome, patients are advised to reduce the frequency of application to once a day or every other day.

Clinicians should counsel patients to keep the product out of reach of children and to seek medical assistance or contact a poison control center immediately if the product is swallowed. Prior to application, patients should ensure that the skin is thoroughly cleaned. New users are encouraged to perform a sensitivity test by applying the product sparingly to one or two small affected areas for the first three days; if no discomfort occurs, they may proceed with the standard application regimen.

Drug Information (PDF)

This file contains official product information for Almay Clear Complexion Concealer, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)